Sandra L. Wegert

Array ( [id] => 7732415 [patent_doc_number] => 20120015396 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-01-19 [patent_title] => 'COMPOSITIONS AND METHODS FOR MODULATING THE ACID-SENSING ION CHANNEL (ASIC)' [patent_app_type] => utility [patent_app_number] => 13/216414 [patent_app_country] => US [patent_app_date] => 2011-08-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 14394 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0015/20120015396.pdf [firstpage_image] =>[orig_patent_app_number] => 13216414 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7581107 [patent_doc_number] => 20110294990 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-12-01 [patent_title] => 'Refolding of Recombinant Proteins' [patent_app_type] => utility [patent_app_number] => 13/196680 [patent_app_country] => US [patent_app_date] => 2011-08-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 16339 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0294/20110294990.pdf [firstpage_image] =>[orig_patent_app_number] => 13196680 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7711731 [patent_doc_number] => 20120004130 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-01-05 [patent_title] => 'AUTOIMMUNE DISEASE BIOMARKERS' [patent_app_type] => utility [patent_app_number] => 13/153262 [patent_app_country] => US [patent_app_date] => 2011-06-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 44536 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13153262 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6111246 [patent_doc_number] => 20110189698 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-08-04 [patent_title] => 'Protein Biomarkers and Methods for Diagnosing Kawasaki Disease' [patent_app_type] => utility [patent_app_number] => 13/036751 [patent_app_country] => US [patent_app_date] => 2011-02-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 21 [patent_figures_cnt] => 21 [patent_no_of_words] => 12907 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0189/20110189698.pdf [firstpage_image] =>[orig_patent_app_number] => 13036751 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6063091 [patent_doc_number] => 20110201029 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-08-18 [patent_title] => 'IL-13 RECEPTOR ANTIBODIES' [patent_app_type] => utility [patent_app_number] => 13/027425 [patent_app_country] => US [patent_app_date] => 2011-02-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 18 [patent_no_of_words] => 11534 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0201/20110201029.pdf [firstpage_image] =>[orig_patent_app_number] => 13027425 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8538024 [patent_doc_number] => 08313745 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-11-20 [patent_title] => 'Compositions against cancer antigen LIV-1 and uses thereof' [patent_app_type] => utility [patent_app_number] => 12/796244 [patent_app_country] => US [patent_app_date] => 2010-06-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 18106 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 58 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12796244 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6538627 [patent_doc_number] => 20100221760 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-09-02 [patent_title] => 'METHODS AND COMPOSITIONS FOR DETECTING AND QUANTIFYING sAPPbeta' [patent_app_type] => utility [patent_app_number] => 12/710965 [patent_app_country] => US [patent_app_date] => 2010-02-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 18 [patent_no_of_words] => 10980 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0221/20100221760.pdf [firstpage_image] =>[orig_patent_app_number] => 12710965 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6229886 [patent_doc_number] => 20100184096 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-07-22 [patent_title] => 'SCREENING METHODS USING SITOSTEROLEMIA SUSCEPTIBILITY GENE (SSG) POLYPEPTIDES' [patent_app_type] => utility [patent_app_number] => 12/705169 [patent_app_country] => US [patent_app_date] => 2010-02-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 20 [patent_figures_cnt] => 20 [patent_no_of_words] => 28974 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0184/20100184096.pdf [firstpage_image] =>[orig_patent_app_number] => 12705169 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8701707 [patent_doc_number] => 08394929 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-03-12 [patent_title] => 'Nogo receptor-mediated blockade of axonal growth' [patent_app_type] => utility [patent_app_number] => 12/693940 [patent_app_country] => US [patent_app_date] => 2010-01-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 31 [patent_figures_cnt] => 49 [patent_no_of_words] => 30959 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 39 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12693940 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6229770 [patent_doc_number] => 20100184064 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-07-22 [patent_title] => 'DNA MOLECULES ENCODING LIGAND GATED ION CHANNELS FROM DERMACENTOR VARIABILIS' [patent_app_type] => utility [patent_app_number] => 12/684705 [patent_app_country] => US [patent_app_date] => 2010-01-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 17 [patent_no_of_words] => 21113 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0184/20100184064.pdf [firstpage_image] =>[orig_patent_app_number] => 12684705 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6339779 [patent_doc_number] => 20100247502 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-09-30 [patent_title] => 'TUMOR/B-CELL HYBRID CELLS AND USES THEREOF' [patent_app_type] => utility [patent_app_number] => 12/683367 [patent_app_country] => US [patent_app_date] => 2010-01-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 10672 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0247/20100247502.pdf [firstpage_image] =>[orig_patent_app_number] => 12683367 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8306033 [patent_doc_number] => 08227575 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-07-24 [patent_title] => 'Cytokine zalpha11 ligand antibodies' [patent_app_type] => utility [patent_app_number] => 12/626307 [patent_app_country] => US [patent_app_date] => 2009-11-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 70905 [patent_no_of_claims] => 41 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 30 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12626307 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6367410 [patent_doc_number] => 20100074841 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-03-25 [patent_title] => 'Compositions Against Cancer Antigen LIV-1 and Uses Thereof' [patent_app_type] => utility [patent_app_number] => 12/622298 [patent_app_country] => US [patent_app_date] => 2009-11-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 18032 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0074/20100074841.pdf [firstpage_image] =>[orig_patent_app_number] => 12622298 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6588895 [patent_doc_number] => 20100062002 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-03-11 [patent_title] => 'Brain Endothelial Cell Expression Patterns' [patent_app_type] => utility [patent_app_number] => 12/616600 [patent_app_country] => US [patent_app_date] => 2009-11-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 25054 [patent_no_of_claims] => 67 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0062/20100062002.pdf [firstpage_image] =>[orig_patent_app_number] => 12616600 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8712845 [patent_doc_number] => 08398984 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-03-19 [patent_title] => 'Removal promoters and inhibitor for apoptosis cells in vivo' [patent_app_type] => utility [patent_app_number] => 12/585997 [patent_app_country] => US [patent_app_date] => 2009-09-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 21 [patent_no_of_words] => 10960 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 32 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12585997 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8533546 [patent_doc_number] => 08309701 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-11-13 [patent_title] => 'Variants of human taste receptor genes' [patent_app_type] => utility [patent_app_number] => 12/534505 [patent_app_country] => US [patent_app_date] => 2009-08-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 9 [patent_no_of_words] => 53187 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 52 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12534505 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6340016 [patent_doc_number] => 20100247540 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-09-30 [patent_title] => 'Methods and Compositions For Modulating Angiogenesis' [patent_app_type] => utility [patent_app_number] => 12/506199 [patent_app_country] => US [patent_app_date] => 2009-07-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 31391 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0247/20100247540.pdf [firstpage_image] =>[orig_patent_app_number] => 12506199 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5397795 [patent_doc_number] => 20090317858 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-12-24 [patent_title] => 'CELLULAR ASSAYS FOR SIGNALING RECEPTORS' [patent_app_type] => utility [patent_app_number] => 12/486620 [patent_app_country] => US [patent_app_date] => 2009-06-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 29 [patent_figures_cnt] => 29 [patent_no_of_words] => 44213 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0317/20090317858.pdf [firstpage_image] =>[orig_patent_app_number] => 12486620 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5315487 [patent_doc_number] => 20090280085 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-11-12 [patent_title] => 'Long Acting Human Interferon Analogs' [patent_app_type] => utility [patent_app_number] => 12/475490 [patent_app_country] => US [patent_app_date] => 2009-05-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 13226 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0280/20090280085.pdf [firstpage_image] =>[orig_patent_app_number] => 12475490 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5385232 [patent_doc_number] => 20090226477 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-09-10 [patent_title] => 'PTH2 RECEPTOR SELECTIVE COMPOUNDS' [patent_app_type] => utility [patent_app_number] => 12/413303 [patent_app_country] => US [patent_app_date] => 2009-03-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11711 [patent_no_of_claims] => 47 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0226/20090226477.pdf [firstpage_image] =>[orig_patent_app_number] => 12413303 [rel_patent_id] =>[rel_patent_doc_number] =>)